[18F]FMISO PET/CT as a preoperative prognostic factor in patients with pancreatic cancer

[18F]FMISO PET/CT as a preoperative prognostic factor in patients with pancreatic cancer

Abstract Background While [18F]fluoromisonidazole (FMISO), a representative PET tracer to detect hypoxia, is reported to be able to prospect the prognosis after treatment for various types of cancers, the relation is unclear for pancreatic cancer. The aim of this study is to assess the feasibility o...

Full description

Bibliographic Details
Main Authors: Tomohiko Yamane, Masayasu Aikawa, Masanori Yasuda, Kenji Fukushima, Akira Seto, Koujun Okamoto, Isamu Koyama, Ichiei Kuji
Format: Article
Language:English
Published: SpringerOpen 2019-05-01
Series:EJNMMI Research
Subjects:
Hypoxia
Pancreas
F-18 fluoromisonidazole (F-18 FMISO)
HIF-1 alfa
Surgery
Operation
Online Access:http://link.springer.com/article/10.1186/s13550-019-0507-8

Internet

http://link.springer.com/article/10.1186/s13550-019-0507-8

Similar Items